Mankind Pharma has acquired Bharat Serums and Vaccines (BSV) for ₹13,630 crore, marking a significant expansion in the women's health and fertility market.
This acquisition includes BSV's strong product portfolio, including niche biologics and critical care drugs, and its R&D capabilities with over 60 scientists This strategic purchase also adds 2,500 BSV employees to Mankind, strengthening its market position.